Ben Tre Pharmaceutical JSC

Ben Tre Pharmaceutical JSC FCF Yield

The Free Cash Flow Yield of Ben Tre Pharmaceutical JSC (DBT.VN) as of Oct 31, 2026 is -49.58 %. In the previous year, Free Cash Flow Yield was -2.92 % — a change of 1,598.64% (lower).

FCF Yield

-49.58 %

YoY

1,598.64%

Last updated:

Free Cash Flow Yield of Ben Tre Pharmaceutical JSC is 2024 -49.58 % . Free Cash Flow Yield of Ben Tre Pharmaceutical JSC was 2023 -2.92 % . It decreases by 1,598.64% lower compared to the previous year.

The Ben Tre Pharmaceutical JSC FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2017
17.65 VND
Jan 1, 2018
-8.95 VND
Jan 1, 2019
-33.96 VND
Jan 1, 2020
-44.99 VND
Jan 1, 2021
-19.78 VND
Jan 1, 2022
-23.22 VND
Jan 1, 2023
-2.92 VND
Jan 1, 2024
-49.58 VND
The Ben Tre Pharmaceutical JSC FCF Yield history
YEARFCF YieldYoY
-49.58 %+1,598.64%
-2.92 %-87.43%
-23.22 %+17.38%
-19.78 %-56.03%
-44.99 %+32.47%
-33.96 %+279.51%
-8.95 %-150.71%
17.65 %+49.08%
11.84 %+221.01%
3.69 %-175.12%
-4.91 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ben Tre Pharmaceutical JSC Stock analysis

What does Ben Tre Pharmaceutical JSC do? Ben Tre Pharmaceutical JSC manufactures and distributes pharmaceutical products, including medicinal products through its subsidiaries. The company wholesales, imports, and exports pharmaceuticals, materials, chemicals, packagings, and biological products. It also retails drugs and trades supplements, medical equipment, supplies, and machinery. The firm rents commercial space for additional revenue. Its primary customers are healthcare providers, pharmacies, and medical institutions requiring pharmaceuticals and medical supplies. The company's revenue streams include pharmaceutical manufacturing, wholesale distribution, import/export services, retail drug sales, and commercial space rentals. Key segments are pharmaceuticals, medical equipment, and biological products. The firm serves healthcare sectors through its subsidiaries and direct retail channels. Revenue is generated from both domestic and international trade activities. Ben Tre Pharmaceutical JSC's products include pharmaceuticals, medicinal products, medical equipment, and supplements. The company's brands are not specified in the business description. It targets healthcare providers, pharmacies, and medical institutions as its main buyers. The firm's operations span manufacturing, distribution, retail, and commercial leasing within the pharmaceutical and medical sectors. Ben Tre Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ben Tre Pharmaceutical JSC stock

Free Cash Flow Yield of Ben Tre Pharmaceutical JSC is -49.58 % in 2024.

Free Cash Flow Yield of Ben Tre Pharmaceutical JSC changed from -2.92 % to -49.58 %, representing a 1,598.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Ben Tre Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Ben Tre Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Ben Tre Pharmaceutical JSC

All Key Metrics — Ben Tre Pharmaceutical JSC